2.98
2.98 (-1.53%)
As of Jun 14, 2022
Immunitybio, Inc. [IBRX]
Source:
Company Overview
ImmunityBio, Inc. is a clinical-stage biotechnology company developing next-generation therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (844) 696-5235 |
| Industry | manufacturing |
| CEO | Richard Adcock |
| Website | www.immunitybio.com |